BusinessHospital Stocks Face Pressure Amid Supreme Court Drug Pricing Review
Hospital company stocks declined after the Supreme Court questioned high mark-ups on cancer medicines during a drug pricing petition hearing on 22 September. The court asked why the 16% trade margin for scheduled drugs isn't applied to non-scheduled drugs. Investors are closely watching the next hearing set for 12 October for further developments.
Mint Markets·




